Cost-utility analysis of pacemakers for the treatment of vasovagal syncope.
نویسندگان
چکیده
Dual-chamber pacing is a promising treatment for patients with very frequent vasovagal syncope, but its cost utility is unknown. We report that the incremental cost per quality-adjusted life-year gained is $13,159 Canadian dollars (about $8,600 US dollars), and therefore this pacemaker therapy for vasovagal syncope has a favorable cost-utility ratio.
منابع مشابه
Prediction of Vasovagal Syncope based on Body Vigilance and Alexithymia Variables
Introduction: Vasovagal syncope is the most common type of syncope and recurrent syncope attacks can have a profound effect on the patients' quality of life. The aim of this study was to predict vasovagal syncope based on the variables of body vigilance and alexithymia. Methods: The present study was a case-control study. The statistical population of the present study included the patients wi...
متن کاملVasovagal Syncope Treated as Epilepsy for 16 Years
The differentiation of vasovagal syncope and epileptic seizure is sometimes problematic, since vasovagal syncope may mimic epileptic seizures in many ways. The present report describes a patient who had been diagnosed and treated as having epilepsy with medically-refractory sei-zures for 16 years. Often, unlike epileptic seizures, tonic-clonic convulsions and postictal confusion are uncommon fe...
متن کاملPermanent pacing for cardioinhibitory malignant vasovagal syndrome.
OBJECTIVE To evaluate the effect of permanent pacing in cardioinhibitory malignant vasovagal syndrome. PATIENTS AND METHODS 37 patients with permanent pacemakers for cardioinhibitory malignant vasovagal syndrome. All presented with syncope (median six episodes, median frequency two episodes a year) and after conventional investigation and invasive electrophysiological assessment they remained...
متن کاملPhysiological Phenomenology of Neurally-Mediated Syncope with Management Implications
BACKGROUND Due to lack of efficacy in recent trials, current guidelines for the treatment of neurally-mediated (vasovagal) syncope do not promote cardiac pacemaker implantation. However, the finding of asystole during head-up tilt -induced (pre)syncope may lead to excessive cardioinhibitory syncope diagnosis and treatment with cardiac pacemakers as blood pressure is often discontinuously measur...
متن کامل9 Widening Indications
Apart from support of heart rate in patients of symptomatic bradycardia, in the last two decades, the indications of pacemakers have widened to prevent arrhythmias, optimise hemodynamic functions and suppress tachyarrhythmias. Pacemakers have been successfully used in Hypertrophic Obstructive Cardiomyopathy (HOCM) to reduce LVOT gradient and in improving cardiac output in patients of dilated ca...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The American journal of cardiology
دوره 84 11 شماره
صفحات -
تاریخ انتشار 1999